Skip to main content
logo
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.580
-0.520 (-24.76%)
At close: Aug 28, 2026, 4:00 PM EDT
1.510
-0.070 (-4.43%)
After-hours: Aug 28, 2026, 7:59 PM EDT

Celularity Revenue

In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. Celularity had revenue of $4.10M in the quarter ending December 31, 2025, a decrease of -77.37%.

Revenue (ttm)
$26.55M
Revenue Growth
-51.03%
P/S Ratio
1.72
Revenue / Employee
$230,870
Employees
115
Market Cap
45.73M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202526.55M-27.67M-51.03%
Dec 31, 202454.22M31.45M138.11%
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M--
Dec 31, 2019---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Karyopharm Therapeutics146.62M
Aligos Therapeutics31.52M
Werewolf Therapeutics21.00M
Veru Inc.16.89M
Metagenomi Therapeutics13.56M
Seres Therapeutics1.88M
Hyperion DeFi1.40M
Impact BioMedical35.00K
Revenue Rankings

CELU News

More News